Design Therapeutics, Inc.
DSGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$49,588 | -$66,862 | -$63,308 | -$35,533 |
| Dep. & Amort. | -$5,602 | $537 | $406 | $129 |
| Deferred Tax | $0 | $0 | $0 | -$77 |
| Stock-Based Comp. | $13,072 | $13,088 | $10,925 | $4,689 |
| Change in WC | -$993 | $728 | $1,992 | $1,396 |
| Other Non-Cash | $6 | -$6,051 | -$1,332 | $19 |
| Operating Cash Flow | -$43,105 | -$58,560 | -$51,317 | -$29,377 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$340 | -$256 | -$918 | -$1,538 |
| Net Acquisitions | $0 | $0 | $39 | $52 |
| Inv. Purchases | -$230,175 | -$224,703 | -$312,998 | -$86,261 |
| Inv. Sales/Matur. | $274,470 | $277,495 | $92,890 | $34,155 |
| Other Inv. Act. | $0 | $0 | $0 | -$52 |
| Investing Cash Flow | $43,955 | $52,536 | -$220,987 | -$53,644 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $513 | $724 | $662 | $254,271 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$427 | $124,940 |
| Financing Cash Flow | $513 | $724 | $235 | $379,211 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $1,363 | -$5,300 | -$272,069 | $296,190 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $21,200 | $26,500 | $298,569 | $2,379 |
| End Cash | $22,563 | $21,200 | $26,500 | $298,569 |
| Free Cash Flow | -$43,445 | -$58,816 | -$52,235 | -$30,915 |